This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Research has shown that mistreatment at the hands of patients and other visitors is one of the leading drivers of burnout in the U.S. healthcare system. The new Cardio Safe initiative was built to combat that issue and protect the well-being of cardiologists and other cardiovascular health professionals.
Analyzing more than 1,500 cases of patients who got sent from an acute-care hospital to an ostensibly more-capable facility, Harvard researchers have found 1 in 4 such transfers could—and probably should—have been avoided.
The American Heart Association, American College of Cardiology and other U.S. medical societies have collaborated on new recommendations that cover everything from preoperative patient evaluations to postoperative care.
A little more than half a year after establishing a healthcare affordability lab, Yale University is out with freshly detailed policy prescriptions for cutting costs without compromising care.
The agency said the move comes after a May 2026 audit of Medicaid outcomes found that states are motivated more by a desire to check boxes than to ensure patients are healthy. Once completed, the new framework will ideally align financial incentives with care outcomes.
Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.
The American College of Cardiology and American Heart Association published the new guidelines with assistance from other leading U.S. medical societies.
Fewer than one-third of primary care clinicians have a say in selecting the AI products their institutions expect them to fold into their clinical workflows. That’s a problem.
Second-generation TAVR valves from Medtronic, Edwards Lifesciences and Boston Scientific are all associated with similar seven-year outcomes, according to a new retrospective study out of Italy.
Cardiologist Aakriti Gupta, MD, MSc, spoke to Cardiovascular Business about the latest data and trends associated with using cerebral embolic protection devices during TAVR to lower the risk of stroke.